Kenya's response to the COVID-19 pandemic: a balance between minimising morbidity and adverse economic impact.
COVID-19
Kenya
disease control measures
pandemic response
transmission
Journal
AAS open research
ISSN: 2515-9321
Titre abrégé: AAS Open Res
Pays: England
ID NLM: 101740247
Informations de publication
Date de publication:
2021
2021
Historique:
accepted:
13
11
2020
entrez:
12
3
2021
pubmed:
13
3
2021
medline:
13
3
2021
Statut:
epublish
Résumé
Coronavirus disease 2019 (COVID-19) has ravaged the world's socioeconomic systems forcing many governments across the globe to implement unprecedented stringent mitigation measures to restrain its rapid spread and adverse effects. A disproportionate number of COVID-19 related morbidities and mortalities were predicted to occur in Africa. However, Africa still has a lower than predicted number of cases, 4% of the global pandemic burden. In this open letter, we highlight some of the early stringent countermeasures implemented in Kenya, a sub-Saharan African country, to avert the severe effects of the COVID-19 pandemic. These mitigation measures strike a balance between minimising COVID-19 associated morbidity and fatalities and its adverse economic impact, and taken together have significantly dampened the pandemic's impact on Kenya's populace.
Identifiants
pubmed: 33709055
doi: 10.12688/aasopenres.13156.1
pmc: PMC7921885
doi:
Types de publication
Journal Article
Langues
eng
Pagination
3Informations de copyright
Copyright: © 2021 Wangari EN et al.
Déclaration de conflit d'intérêts
No competing interests were disclosed.
Références
Curr Opin Virol. 2016 Feb;16:70-76
pubmed: 26855039
Infect Dis Poverty. 2020 Apr 7;9(1):34
pubmed: 32264957
Wellcome Open Res. 2018 Jul 6;3:82
pubmed: 30430140
Sci Rep. 2017 Aug 11;7(1):7974
pubmed: 28801623
Epidemiology. 2020 Jul;31(4):567-569
pubmed: 32324625
Science. 2020 Aug 7;369(6504):624-626
pubmed: 32764055
Front Pharmacol. 2020 Sep 11;11:1205
pubmed: 33071775
BMC Public Health. 2018 Jan 17;18(1):146
pubmed: 29343225
BMJ Glob Health. 2020 May;5(5):
pubmed: 32409328
BMC Med. 2020 Oct 5;18(1):316
pubmed: 33012285
Science. 2021 Jan 1;371(6524):79-82
pubmed: 33177105
Front Pharmacol. 2021 Jan 14;11:588106
pubmed: 33628173
MMWR Morb Mortal Wkly Rep. 2020 May 08;69(18):540-544
pubmed: 32379727
J Infect Dev Ctries. 2020 Aug 31;14(8):838-843
pubmed: 32903226
BMJ Glob Health. 2020 May;5(5):
pubmed: 32451366
Lancet. 2020 Feb 29;395(10225):676
pubmed: 32113495